Literature DB >> 14568903

Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.

Zoltán Lakó-Futó1, István Szokodi, Balázs Sármán, Gábor Földes, Heikki Tokola, Mika Ilves, Hanna Leskinen, Olli Vuolteenaho, Réka Skoumal, Rudolf deChâtel, Heikki Ruskoaho, Miklós Tóth.   

Abstract

BACKGROUND: The precise function of angiotensin II type 2 receptor (AT2-R) in the mammalian heart in vivo is unknown. Here, we investigated the role of AT2-R in cardiac pressure overload. METHODS AND
RESULTS: Rats were infused with vehicle, angiotensin II (Ang II), PD123319 (an AT2-R antagonist), or the combination of Ang II and PD123319 via subcutaneously implanted osmotic minipumps for 12 or 72 hours. Ang II-induced increases in mean arterial pressure, left ventricular weight/body weight ratio, and elevation of skeletal alpha-actin and beta-myosin heavy chain mRNA levels were not altered by PD123319. In contrast, AT2-R blockade resulted in a marked increase in the gene expression of c-fos, endothelin-1, and insulin-like growth factor-1 in Ang II-induced hypertension. In parallel, Ang II-stimulated mRNA and protein expression of atrial natriuretic peptide were significantly augmented by AT2-R blockade. Moreover, PD123319 markedly increased the synthesis of B-type natriuretic peptide. Furthermore, the expression of vascular endothelial growth factor and fibroblast growth factor-1 was downregulated by Ang II only in the presence of AT2-R blockade.
CONCLUSIONS: Our results provide evidence that AT2-R plays a functional role in the cardiac hypertrophic process in vivo by selectively regulating the expression of growth-promoting and growth-inhibiting factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568903     DOI: 10.1161/01.CIR.0000093193.63314.D9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 2.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Cardiac insulin resistance and microRNA modulators.

Authors:  Lakshmi Pulakat; Annayya R Aroor; Rukhsana Gul; James R Sowers
Journal:  Exp Diabetes Res       Date:  2011-07-31

4.  Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency.

Authors:  Venla Kurra; Tuija Vehmas; Arttu Eräranta; Jarkko Jokihaara; Päivi Pirttiniemi; Heikki Ruskoaho; Heikki Tokola; Onni Niemelä; Jukka Mustonen; Ilkka Pörsti
Journal:  BMC Nephrol       Date:  2015-03-27       Impact factor: 2.388

5.  Buckwheat Rutin Inhibits AngII-induced Cardiomyocyte Hypertrophy via Blockade of CaN-dependent Signal Pathway.

Authors:  Jin-Xiu Chu; Guang-Min Li; Xiu-Juan Gao; Jian-Xing Wang; Shu-Ying Han
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 6.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

7.  In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.

Authors:  Guillem Jorba; Joaquim Aguirre-Plans; Valentin Junet; Cristina Segú-Vergés; José Luis Ruiz; Albert Pujol; Narcís Fernández-Fuentes; José Manuel Mas; Baldo Oliva
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

8.  Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.

Authors:  Se Min Ryu; Hark Jei Kim; Kyu Ran Cho; Won-Min Jo
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

9.  (Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function.

Authors:  Anne-Mari Moilanen; Jaana Rysä; Raisa Serpi; Erja Mustonen; Zoltán Szabò; Jani Aro; Juha Näpänkangas; Olli Tenhunen; Meeri Sutinen; Tuula Salo; Heikki Ruskoaho
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function.

Authors:  Anne-Mari Moilanen; Jaana Rysä; Leena Kaikkonen; Teemu Karvonen; Erja Mustonen; Raisa Serpi; Zoltán Szabó; Olli Tenhunen; Zsolt Bagyura; Juha Näpänkangas; Pauli Ohukainen; Pasi Tavi; Risto Kerkelä; Margrét Leósdóttir; Björn Wahlstrand; Thomas Hedner; Olle Melander; Heikki Ruskoaho
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.